Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S. physician preference data for the SOFIA™ 88 ...

Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters Provided by PR Newswire Jul 14, 2025, 6:00:00 AM ...

"These real-world results further validate SOFIATM 88 catheter's position as a leading super-bore support catheter," said Carsten Schroeder, President and CEO of Terumo Neuro. "This new dataset ...

The interventional radiology market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the ...

Covid-19 Neurological Issues: A recent Nimhans study finds that Covid-19 may cause serious neurological disorders, affecting a significant number of patients beyond respiratory issues. Discover ...

Overview of Plasmapheresis MarketThe Global Plasmapheresis Market is valued at USD 1.34 Billion in 2024 and is projected to ...

Patients with functional neurologic disorder (FND) after SARS-CoV-2 infection had different symptoms than people with FND after COVID vaccines, retrospective data showed. Patients with post-COVID ...

GABA, or gamma-aminobutyric acid, is an amino acid functioning as the principal inhibitory neurotransmitter that can act on the brain to slow or stop the reception of certain signals to the brain ...

Find the latest Neurology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.

View the latest Terumo Corp. (TRUMF) stock price, news, historical charts, analyst ratings and financial information from WSJ.